VCG
NTUS

Vantage Consulting Group’s Natus Medical Inc NTUS Stock Holding History

Vantage Consulting Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-954
Closed -$19K – 1769
2020
Q4 		$19K Buy
+954
New +$18.7K ﹤0.01% 907

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vantage Consulting Group's NTUS Position: Q1 2021 in Review

Vantage Consulting Group sold out of Natus Medical Inc (NTUS) in Q1 2021, closing a stake of 954 shares — an estimated $19K sold.

Vantage Consulting Group first reported a position in NTUS in Q4 2020 and held it in 1 quarter. The position peaked at $19K in Q4 2020. 156 funds tracked by Wall St. Rank hold NTUS as of Q1 2021.

  • Vantage Consulting Group reported no remaining Natus Medical Inc position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 954 Natus Medical Inc shares in Q1 2021, an estimated $19K.
  • Vantage Consulting Group first reported a position in Natus Medical Inc in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Natus Medical Inc position peaked at $19K in Q4 2020.
  • 156 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.